Literature DB >> 8583078

Screening for asymptomatic celiac sprue in families.

H Vazquez1, E Sugai, S Pedreira, S Katz, N Litwin, S De Rosa, J Ruiz, G Soifer, Z Kogan, L Boerr.   

Abstract

We evaluated the reliability of IgA and IgG antigliadin antibodies (AGA-A, AGA-G), antireticulin antibody (ARA), endomysial antibodies (EmA), and alpha 1-antitrypsin clearance (alpha 1-AT CL) in the detection of celiac sprue (CS) in 59 first-degree asymptomatic relatives of celiac patients who had duodenal biopsy. Twenty-four relatives who had normal results of screening tests were selected at random for biopsy; 35 relatives with at least one abnormal test result were biopsied. Eleven relatives were noted to have villous atrophy at biopsy; the diagnosis of celiac sprue was confirmed by histological improvement after gluten-free diet in six. AGA-G, alpha 1-AT CL, and EmA had sensitivities of 73%, 73%, and 64%, respectively, with very high levels of specificity. Sensitivity was improved by the combination of two serological markers (AGA-G + alpha 1-AT CL = 91%; AGA-G + EmA = 82%; EmA + ARA = 82%). Furthermore, combination of EmA and ARA has shown the best specificity and positive predictive value. AGA-G, alpha 1-AT CL, and EmA are reliable individual markers for the detection of asymptomatic celiac sprue. However, a combination of two of them, including ARA, was more sensitive than the individual tests.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8583078     DOI: 10.1097/00004836-199509000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  3 in total

1.  Serological markers and HLA-DQ2 haplotype among first-degree relatives of celiac patients. Catalonian Coeliac Disease Study Group.

Authors:  C Farré; P Humbert; P Vilar; V Varea; X Aldeguer; J Carnicer; M Carballo; M A Gassull
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

2.  Screening for celiac disease in family members: is follow-up testing necessary?

Authors:  David Goldberg; Debbie Kryszak; Alessio Fasano; Peter H R Green
Journal:  Dig Dis Sci       Date:  2007-02-16       Impact factor: 3.199

3.  Abnormal intestinal permeability in primary biliary cirrhosis.

Authors:  Jordan J Feld; Jonathan Meddings; E Jenny Heathcote
Journal:  Dig Dis Sci       Date:  2006-08-26       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.